Transparency Market Research (TMR) has recently published a report on the global auto-injectors market, according to which, the market is expected to expand at a remarkable CAGR of 18.60% between 2014 and 2020.The air cooler mould research report, titled “Auto-Injectors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” projects this market to increase from a value of US$0.6 bn in 2013 to US$2.5 bn by the end of the forecast period.
 
Auto-injectors are mostly spring-loaded syringes used for injecting oneself with a preloaded, single dose of a drug. These injectors are easy to use and are generally utilized in the case of multiple sclerosis, anaphylaxis, or rheumatoid arthritis. The growing prevalence of anaphylaxis and allergies from food have fueled the demand for auto-injectors globally. Apart from this, the implementation of favorable reimbursement policies by various governments across the world is also propelling this market significantly.
 
The research report presents an in-depth analysis of the global market for auto-injectors. It studies the market on four fronts: The type of product, manufacturing design, application, and the region. Based on the type of product, the market has been categorized into fillable (reusable) auto-injectors and prefilled (disposable) auto-injectors. The prefilled auto-injectors segment enjoys a higher demand than the fillable auto-injectors segment on account of the ease of usage provided by prefilled auto-injectors.
 
By manufacturing design, the market has been classified into standardized auto-injectors and customized auto-injectors. The standardized auto-injectors segment dominated the overall market in 2013. However, analysts anticipate the customized auto-injectors segment to record the fastest growth during the forecast period, states the report.
 
Application-wise, the market has been grouped into rheumatoid arthritis, multiple sclerosis, anaphylaxis, and other applications. In 2013, the demand for auto-injectors was the highest from the anaphylaxis segment.
 
Regionally, the research report has segmented the worldwide market for auto-injectors into North America, Asia Pacific, Europe, and the Rest of the World. North America led the global market in 2013 with a share of 70%. The increased prevalence of anaphylaxis and the rise in the disposable income of individuals, enabling them to afford expensive treatments, have fueled the demand for auto-injectors in this region significantly. The presence of a favorable reimbursement environment has also boosted this regional market in the recent past.